Log In
Print
BCIQ
Print
Print this Print this
 

Xeloda, capecitabine (R340, RG340)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionOral prodrug form of 5-fluorouracil (5-FU)
Molecular Target Thymidylate synthase
Mechanism of ActionThymidylate synthase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today